Onychomycosis: A photodisinfection maintenance regimen for the prevention of recurring onychomycosis

Let’s Talk About Maintenance Programs. Did you know that the ToeFX Therapy Light can successfully prevent re-infections of onychomycosis?   It is well known by clinicians and researchers that onychomycosis patients are commonly susceptible to re-infection. It is a very stubborn condition to successfully treat permanently.  Statistics vary, but studies show the rates of reinfection can be 25-50% or more. Furthermore, it should be recognized that reinfection can occur much later. A year or more can pass before symptoms of the condition return. This can be extremely frustrating for patients.   It is important for clinicians to know that patients…

Read More

How to make ToeFX ClearToe Light Therapy Treatments a Positive Experience for your Patients and Grow Your Business

Patient results and testimonials have shown that ToeFX ClearToe Light Therapy Treatment is now being embraced by clinicians and patients nationwide.  Finally there is a safe and effective solution for onychomycosis to replace topical and oral medications that is painless, drug-free, and has no side effects. The ClearToe Therapy Light uses photodisinfection to target fungal infection. Read about the results and testimonials here. In this blog we will discuss how to make ToeFX Light Therapy Treatments a positive experience for your patient. This can in turn grow your patient base and increase sales for your business.   Offer Superior Care…

Read More

Clinics Embrace Scientifically Proven, Portable, and Cost Effective ClearToe Light Therapy

The aging population of Canada needs foot care clinics that provide dedicated services to help the aging population remain mobile. Having healthy feet is of paramount importance to continuing overall mobility. Onychomycosis is a common fungal infection that causes toenail discoloration, thickening, and separation from the nail bed. The condition occurs in 10% of the general population but is more common among older adults where the infection rate is 20% in those over 60 years of age, and 50% in those over 70 years. Is your clinic offering treatments for toenail fungus that are less effective than they could be?…

Read More

ToeFX ClearToe Therapy: Good for Patients, Good for Business

Are you struggling to find successful treatments for your patients living with Onychomycosis, commonly referred to as Toenail Fungus? Onychomycosis is a very common and progressive medical condition that negatively affects the lives of many people. It is by far the most common nail infection, representing around 50% of all nail diseases and affecting 10% to 20% of adults. It is especially prevalent in the elderly population. Fungal nail infections don’t usually have serious consequences for people who are otherwise healthy, but they rarely go away on their own. If left untreated, the fungus may stay on just one part…

Read More

All toenail fungal infections are not created equal

Introduction to the Onychomycosis Severity Index (OSI) Onychomycosis, a common disease of the nail unit caused by dermatophytes, nondermatophyte molds, and yeasts, has a prevalence of approximately 10-20% worldwide. Currently no standardized system exists to clinically grade the severity of onychomycotic nail disease. Such a scale is necessary for clinical trial inclusion criteria, for critical evaluation of treatment choice, and to help predict therapeutic outcome. Having quantitative numbers can also assist when discussing these factors with patients and other clinicians. Inconsistences in onychomycotic grading systems can also lead to confusion about interpretation of efficacy. Recently, in a trial of ciclopirox…

Read More

ToeFX announces new partnership with McMaster University

ToeFX is driven by innovation. The vision of our science team is to create the world’s most effective foot care treatments. As such, we continually conduct research to improve our understanding of one of the world’s most stubborn and prevalent infections – onychomycosis.  In order to treat even the most complex cases of onychomycosis, we need to take a holistic treatment approach – from diagnostics to follow-up.  One area of intense focus for ToeFX is diagnostics. We are excited to announce that starting this autumn, we are launching a new collaboration with Professor Jianping Xu from the McMaster University. The…

Read More

How to effectively incorporate ToeFX into your practice

Interview with Dr Joanne Lih, Podiatrist, about the ToeFX ClearToe Therapy System You currently have 17 patients using ToeFX, with 10 more waiting to begin their treatment. How has it been incorporating ToeFX into your busy schedule? As a solo practitioner, I recommend to start slow, space patients as you need, and watch your timing. I’ve learned that scheduling ToeFX patients first thing in the morning and at the end of the day works best for my practice. Also, I use a colour coded system for scheduling, with one colour unique for my ToeFX visits, which has helped me plan…

Read More

Cycling and Toenail Fungus

ToeFX co-founder Dr Irit Van-Ham enjoys cycling….here she weighs in on the commonalities between cycling and toenail fungus. According to recent studies, some 6-20% of people worldwide suffer from fungal nail infections or onychomycosis. It’s even more common in seniors: it affects 50% of those over 70. This infection can have serious health implications. When the toenail (big toe) breaks off from the skin, bacteria can enter the wound, making the area more susceptible to infection. But what has cycling got to do with toenail fungus? Here are some common features: 1) It does not take a lot to grow:…

Read More

ToeFX selected for the OBIO-CAAP 2021 cohort

We are excited at being selected to be in this year’s cohort of 2021 Capital Access Advisory Program from The Ontario Bioscience Innovation Organization. Proud to be recognized as a high potential health science company and looking forward to continuing the momentum with many more innovative solutions. The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2021 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s cohort.

Read More

ToeFX wins Ontario’s premier life sciences competition

winners-synapse

On March 24, ToeFX took home the grand prize in the Synapse Competition, Ontario’s premier life science pitch competition. The Synapse Competition is dedicated to fostering the commercialization of innovation in the life science sector. Delivered by Innovation Factory, in collaboration with the Synapse Consortium, the competition supports innovators, scientists and researchers to launch their ideas to market, increase revenues, attract investment, and create jobs. “The ToeFX team is delighted and proud to have been selected as the winner of the Synapse Life Science Competition 2021. This recognition will propel us forward as we strive to become the global standard…

Read More